Corrigendum to "Emerging strategy for the treatment of urothelial carcinoma : Advances in antibody-drug conjugates combination therapy" Biomed. Pharmacother. 171 (2024) 116152
| Errataetall: |
ErratumFor: Biomed Pharmacother. 2024 Feb;171:116152. - PMID 38228034 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:173 |
|---|---|
| Enthalten in: |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 173(2024) vom: 12. März, Seite 116430 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
You, Xiangyun [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 26.03.2024 published: Print-Electronic ErratumFor: Biomed Pharmacother. 2024 Feb;171:116152. - PMID 38228034 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.biopha.2024.116430 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369753038 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369753038 | ||
| 003 | DE-627 | ||
| 005 | 20240326235851.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.biopha.2024.116430 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1349.xml |
| 035 | |a (DE-627)NLM369753038 | ||
| 035 | |a (NLM)38485617 | ||
| 035 | |a (PII)S0753-3322(24)00314-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a You, Xiangyun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "Emerging strategy for the treatment of urothelial carcinoma |b Advances in antibody-drug conjugates combination therapy" Biomed. Pharmacother. 171 (2024) 116152 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Biomed Pharmacother. 2024 Feb;171:116152. - PMID 38228034 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Zhu, Chunming |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Puguang |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Xia |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yibing |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Jiahe |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Junfeng |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Kefeng |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |d 1984 |g 173(2024) vom: 12. März, Seite 116430 |w (DE-627)NLM012645591 |x 1950-6007 |7 nnns |
| 773 | 1 | 8 | |g volume:173 |g year:2024 |g day:12 |g month:03 |g pages:116430 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.biopha.2024.116430 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 173 |j 2024 |b 12 |c 03 |h 116430 | ||